SIGA Technologies (SIGA) Stock Analysis & AI Equity Report

Drug Manufacturers - Specialty & Generic USD Explore free reports

SIGA Technologies (SIGA) overview

SIGA Technologies (SIGA) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 94.6m and operating profit of USD 23.7m; the year-end share price was 6.11 USD and market capitalisation was USD 438m. SIGA Technologies is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get SIGA Technologies's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 199mFY 2025
Share price6.11 USDFY 2025 year end
RevenueUSD 94.6mFY 2025
Operating profitUSD 23.7mFY 2025
Net earningsUSD 23.3mFY 2025
Market capitalisationUSD 438mFY 2025 year end

About SIGA Technologies

SIGA Technologies is a commercial-stage pharmaceutical company that sells oral and intravenous formulations of TPOXX, an antiviral drug for treating smallpox. Its customers include the U.S. government, international governments and government-affiliated entities; in some international markets, sales are made through distributors. Oral TPOXX is also approved in several markets for other orthopoxvirus conditions.

Generate the SIGA Technologies report

SIGA Technologies is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for SIGA Technologies and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on SIGA Technologies

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.